{
    "name": "Sales of products, mixtures, or preparations containing pseudoephedrine; reporting requirement for wholesalers",
    "number": "75",
    "text": "(a)  Notwithstanding any other law to the contrary, a pharmacy or retailer may dispense, sell, or distribute without a prescription not more than three packages or not more than nine grams per transaction, of any product, mixture, or preparation containing any detectable quantity of pseudoephedrine, its salts, optical isomers, or salts of optical isomers, as the only active ingredient or in combination with other active ingredients; provided that the pharmacy or retailer complies with the following conditions:\n\n\n\n\t(1)\tThe product, mixture, or preparation shall be dispensed, sold, or distributed from an area that is in the direct line of sight of an employee at the checkout station or counter;\n\t(2)\tThe product, mixture, or preparation shall be dispensed, sold, or distributed from an area that is under constant video monitoring with signage placed near the drug that warns that the area is under constant video monitoring; or\n\t(3)\tThe product, mixture, or preparation shall be dispensed, sold, or distributed from an area not accessible by customers or the general public, such as behind the counter or in a locked display case.\n\n\n\n\t(b)  The sales restriction in this section, as it applies to products, mixtures, or preparations containing any detectable quantity of pseudoephedrine, its salts, optical isomers, or salts of optical isomers, shall not apply to any products, mixtures, or preparations that are in liquid, liquid capsule, or gel capsule form if pseudoephedrine is not the only active ingredient.\n\t(c)  The department, by rule, may exempt other products from this section, including extended-release pseudoephedrine combination products, if the administrator finds that the products are not used in the illegal manufacture of methamphetamine or other controlled substances.  A manufacturer of a drug product may apply for removal of the product from this section if the product is determined by the administrator to have been formulated in such a way as to effectively prevent the conversion of the active ingredient into methamphetamine.\n\t(d)  Notwithstanding any other provision of this chapter to the contrary, every wholesaler shall report to the administrator all sales made to any retailer, of any product, mixture, or preparation containing any detectable quantity of pseudoephedrine, its salts, optical isomers, or salts of optical isomers, as the only active ingredient or in combination with other active ingredients.  The department shall provide a common reporting form that contains at least the following information about the product, mixture, or preparation:\n\n\n\n\t(1)\tGeneric or other name;\n\t(2)\tQuantity sold;\n\t(3)\tDate of sale;\n\t(4)\tName and address of the wholesaler; and\n\t(5)\tName and address of the retailer.\n\n\n\n\t(e)  For purposes of this section, \"extended-release pseudoephedrine combination product\" means any product containing pseudoephedrine that also contains other ingredients that protect the pseudoephedrine from immediate release and prevent the pseudoephedrine from being extracted. [L 2005, c 193, pt of \u00a71]"
}